Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares BRCA reversion mutations, Saruparib, Rucaparib, Tumour (somatic or germline) BRCA1/2 mutation and HRR gene alterations and the tag subtype-page.
Shares BRCA reversion mutations, Rucaparib, Tumour (somatic or germline) BRCA1/2 mutation and HRR gene alterations, Germline BRCA1/2 pathogenic variant (gBRCAm) and the tag subtype-page.
Shares PSA kinetics: PSA doubling time and PSA density, Biochemical recurrence of prostate cancer, SBRT / SABR (stereotactic radiotherapy), Prostate cancer and the tag subtype-page.
Shares Biochemical recurrence of prostate cancer, Metastatic hormone-sensitive prostate cancer, Abiraterone acetate, Prostate cancer and the tag subtype-page.
Shares Denosumab, Zoledronic acid, Olaparib and the tag subtype-page.
Shares PTEN loss, Talazoparib, Olaparib and the tag subtype-page.
Shares Biochemical recurrence of prostate cancer, SBRT / SABR (stereotactic radiotherapy), Prostate cancer and the tag subtype-page.
Shares Saruparib, Olaparib, Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.